|
PPME1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.148500E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.069600E-01 |
| Normal-vs-Stage2 |
5.452400E-01 |
| Normal-vs-Stage3 |
5.815600E-02 |
| Normal-vs-Stage4 |
9.548200E-02 |
| Stage1-vs-Stage2 |
8.920600E-01 |
| Stage1-vs-Stage3 |
9.761700E-02 |
| Stage1-vs-Stage4 |
1.168990E-01 |
| Stage2-vs-Stage3 |
1.679030E-01 |
| Stage2-vs-Stage4 |
1.321200E-01 |
| Stage3-vs-Stage4 |
2.802800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.628600E-01 |
| Normal-vs-AfricanAmerican |
3.423200E-01 |
| Normal-vs-Asian |
2.087800E-01 |
| Caucasian-vs-AfricanAmerican |
9.523800E-01 |
| Caucasian-vs-Asian |
2.572200E-01 |
| AfricanAmerican-vs-Asian |
2.571200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.770800E-01 |
| Normal-vs-Female |
1.022400E-03 |
| Male-vs-Female |
6.834600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.730190E-01 |
| Normal-vs-Extreme_Weight |
8.438000E-01 |
| Normal-vs-Obese |
1.452610E-01 |
| Normal-vs-Extreme_Obese |
4.371800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.062830E-01 |
| Normal_Weight-vs-Obese |
8.515600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.169000E-01 |
| Extreme_Weight-vs-Obese |
9.273800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.290000E-01 |
| Obese-vs-Extreme_Obese |
1.058370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.426500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.013200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.002400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.527000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.150200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.238200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.947880E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.291000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.441800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.874230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.228400E-01 |
| Normal-VS-Type2 PRCC |
4.551400E-01 |
| Normal-VS-KIRP CIMP |
9.991100E-04 |
| Normal-VS-Unclassified PRCC |
2.761200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.004100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.183790E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
5.316200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.179400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
8.798400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.442470E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.666800E-01 |
| Normal-vs-N1 |
1.756430E-02 |
| Normal-vs-N2 |
3.409400E-01 |
| N0-vs-N1 |
1.828240E-02 |
| N0-vs-N2 |
7.521900E-02 |
| N1-vs-N2 |
7.554000E-01 |
|
|
